NCT04443530 Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical Practice
| NCT ID | NCT04443530 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duk-Woo Park, MD |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2020-09-17 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2020-09-17 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to evaluate the effectiveness and safety of Ultimaster Tansei stent and/or Ultimaster Nagomi stent in the "real-world" daily practice.
Eligibility Criteria
Inclusion Criteria: 1. Patients ≥ 19 years old 2. Patients receiving Ultimaster™ Tansei™ stent and/or Ultimaster Nagomi™ stents. 3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: 1. Patients with a mixture of other drug-eluting stents (DESs) 2. Terminal illness with life-expectancy ≤1 year. 3. Patients with cardiogenic shock
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04443530 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04443530 currently recruiting?
Yes, NCT04443530 is actively recruiting participants. Contact the research team at cvcrc5@amc.seoul.kr for enrollment information.
Where is the NCT04443530 trial being conducted?
This trial is being conducted at Chuncheon, South Korea, Daegu, South Korea, Daegu, South Korea, Daejeon, South Korea and 7 additional locations.
Who is sponsoring the NCT04443530 clinical trial?
NCT04443530 is sponsored by Duk-Woo Park, MD. The trial plans to enroll 2,000 participants.